{"postfix": "vertex_pharmaceuticals-aktie", "name": "VERTEX_PHARMACEUTICALS", "wkn": "882807", "time": "2020.05.26 16:12", "ts": 1590502328, "features": {"KGV": "41.41", "Marktkapitalisierung": {"Size": "Mrd", "Value": "70.17"}, "GA": "5.33", "KBV": "9.38", "BA": "23.53", "KCV": "34.22", "CA": "6.45", "Vola30": "49.28", "Vola90": "59.97", "Vola180": "46.02", "Vola250": "38.1"}, "rivals": ["merck_co-aktie", "bayer-aktie", "novartis-aktie", "pfizer-aktie", "bristol-myers_squibb-aktie", "abbott_laboratories-aktie", "astrazeneca-aktie"], "text_data": {"de": [["01.05.20", "Vertex Pharmaceuticals: So viel setzte das Unternehmen zuletzt um"], ["30.04.20", "So sch\u00e4tzen die Analysten die Zukunft der Vertex Pharmaceuticals-Aktie ein"], ["28.04.20", "Ausblick: Vertex Pharmaceuticals pr\u00e4sentiert Bilanzzahlen zum j\u00fcngsten Jahresviertel"], ["03.02.20", "Vertex Pharmaceuticals hat die Zahlen zum j\u00fcngsten Quartal vorgelegt"], ["29.01.20", "Ausblick: Vertex Pharmaceuticals gew\u00e4hrt Anlegern Blick in die B\u00fccher"]], "en": [["24.05.20", "Is Vertex Pharmaceuticals Stock a Buy?"], ["20.05.20", "The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals"], ["20.05.20", "The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals"], ["19.05.20", "The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology"], ["19.05.20", "Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day"], ["18.05.20", "Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX)"], ["11.05.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["08.05.20", "Zacks.com featured highlights include: Logitech International, MACOM Technology Solutions, Murphy USA, Vertex Pharmaceuticals and The Clorox Company"], ["08.05.20", "3 Reasons to Buy Vertex Pharmaceuticals Stock Right Now"], ["07.05.20", "Zacks.com featured highlights include: Activision Blizzard, Guardant Health, Vertex Pharmaceuticals, Aphria and Shopify"], ["06.05.20", "Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet"], ["06.05.20", "Zacks.com featured highlights include: Cogent Communications, Murphy USA, Vertex Pharmaceuticals and B2Gold"], ["02.05.20", "Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals"], ["30.04.20", "Vertex Pharmaceuticals Inc (VRTX) Q1 2020 Earnings Call Transcript"], ["29.04.20", "Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimates"], ["29.04.20", "The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Sprouts Farmers Market, The Hain Celestial, Virtu Financial and Pixelworks"], ["28.04.20", "Why Vertex Pharmaceuticals (VRTX) Might Surprise This Earnings Season"], ["24.04.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["22.04.20", "Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth"], ["10.04.20", "Where Will Vertex Pharmaceuticals Be in 1 Year?"], ["09.04.20", "Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know"], ["06.04.20", "The Zacks Analyst Blog Highlights: Amazon, Medtronic, Vertex Pharmaceuticals, Intuit and Bayer"], ["03.04.20", "Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know"], ["01.04.20", "Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals"], ["31.03.20", "Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year?"], ["27.03.20", "Vertex Pharmaceuticals to Pause Some Clinical Trials"], ["18.03.20", "Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know"], ["17.03.20", "Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today"], ["17.03.20", "Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals"], ["17.03.20", "The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals"], ["12.03.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["25.02.20", "Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?"], ["21.02.20", "Jim Cramer: Experts are calling Vertex Pharmaceuticals the 'most promising story in biotech'"], ["20.02.20", "Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX)"], ["19.02.20", "Better Buy: Vertex Pharmaceuticals vs. Incyte"], ["12.02.20", "Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain"], ["05.02.20", "Is Vertex Pharmaceuticals (VRTX) Stock Outpacing Its Medical Peers This Year?"], ["02.02.20", "Where Will Vertex Pharmaceuticals Be in 10 Years?"], ["31.01.20", "Is Vertex Pharmaceuticals Stock Still a Strong Buy?"], ["31.01.20", "Vertex Pharmaceuticals Inc (VRTX) Q4 2019 Earnings Call Transcript"], ["2020-05-26 12:17", "2 Top Factors Buoy Wall Street Since Memorial Day: 5 Picks ...  is 53.6% and 23.1%, respectively. For the next year, the company's expected earnings growth rate is 29.2%. Moderna develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases. The company currently has a Zacks Rank #2. The company's expected earnings growth rate for the next five-year period is 33.6%. Vertex Pharmaceuticals Incorporated ( VRTX - Free Report ) , known for developing and commercializing therapies for treating cystic fibrosis, has provided $500,000 to Partners HealthCare to enhance testing capacity vital to limiting the spread of this virus. The company currently has a Zacks Rank #1. The company's expected earnings growth rate for the current quarter and year is 65.9% and 65.1%, respectively ... "], ["2020-05-24 18:04", "Is Vertex Pharmaceuticals Stock a Buy? ... , radio show, and premium investing services. Who Is the Motley Fool? About Us Reviews Foolanthropy Media Inquiries Contact Us Fool Podcasts Motley Fool Money Marketfoolery Industry Focus Motley Fool Answers Rule Breaker Investing Social Media + Facebook Twitter YouTube Discussion Boards CAPS - Stock Picking Community New Ventures The Ascent Millionacres The Blueprint Soapbox Search Search: Is Vertex Pharmaceuticals Stock a Buy? This successful biotech has two big things going for it. Keith Speights (TMFFishBiz) May 24, 2020 at 2:04PM Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical ... "], ["2020-05-24 13:02", "If You'd Invested $10,000 in Moderna's IPO, Here's How Much Money You'd Have Now ...  415% 87% Stock Advisor launched in February of 2002. Returns as of 05/24/2020. Join Stock Advisor Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return Stocks MRNA Moderna INC NASDAQ: MRNA $67.05 down $-6.42 (-8.74%) MRK Merck & Co. NYSE: MRK $76.55 down $0.34 (-0.44%) AZN AstraZeneca NYSE: AZN $55.28 up $1.50 (2.79%) VRTX Vertex Pharmaceuticals NASDAQ: VRTX $284.63 up $0.01 (0.00%) Related Articles Can Moderna Win the Race to Find a COVID-19 Vaccine? Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue Moderna Shares Surged 20% on Coronavirus Vaccine Data. Here's What May Drive Them Higher. Why Moderna Stock Dropped Thursday Will Moderna Stock Surge to $90? If You'd Invested $10,000 in Moderna ... "], ["2020-05-24 11:35", "Here's Why You Might Not Want to Buy Stocks Right Now ...  happens next. Motley Fool Returns Stock Advisor S&P 500 415% 87% Stock Advisor launched in February of 2002. Returns as of 05/24/2020. Join Stock Advisor Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return Stocks AAPL Apple NASDAQ: AAPL $316.85 down $-2.38 (-0.75%) CVS CVS Health NYSE: CVS $63.34 up $0.12 (0.19%) VRTX Vertex Pharmaceuticals NASDAQ: VRTX $284.63 up $0.01 (0.00%) Related Articles 3 Warren Buffett Stocks to Buy Right Now 3 Warren Buffett Stocks Worth Buying Now Surprise! Most FAANG Stocks Are Historically Cheap 3 Warren Buffett Dividend Stocks That You Can Buy Right Now 3 of the Safest Dividend Stocks in the World Here's Why You Might Not Want to Buy Stocks Right Now @themotleyfool #stocks $AAPL ... "], ["2020-05-23 11:45", "The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time (MRNA) ...  few months later, Moderna published the first human data from its platform. The funding kept pouring in, with Moderna completing a $500 million round in early 2018. Later that year, executives filed paperwork to go public. By that time, the company had raised more than $2.5 billion and gained the attention of the drug industry's biggest players, inking deals with Merck and Vertex Pharmaceuticals. The December 2018 IPO was the largest for any biotech: Moderna took in $563 million in net proceeds and was valued at roughly $7.5 billion. By the end of the decade, Moderna had sprung up from Rossi's stem cell research into a biotech force. Then the 2020 pandemic launched Moderna into a new stratosphere of attention. The coronavirus provides Moderna with ... "], ["2020-05-22 20:39", "This work-from-home tool lets you take a real break while tricking your micro-managing boss and judging coworkers into thinking you're still at the keyboard ...  reliant on tools like Microsoft Teams or Slack to determine when someone's \"at their desk.\" Some have even turned to VPNs and webcams to constantly monitor employees throughout the day. That's increased stress levels for some employees \u2014 but it also inspired Rehaan Adatia, a consultant at KPMG, and Haris Akbar, a post-doctoral fellow at Vertex Pharmaceuticals, to find a way to help work-from-homers reclaim some control over their schedule. \"We were seeing an uptick in these micro-managing initiatives taken up by managers to really check in a little bit further on their employees,\" Adatia told Business Insider, adding that a survey they sent around online confirmed that others were having difficulties taking breaks without ... "], ["2020-05-22 20:39", "This work-from-home tool lets you take a real break while tricking your micro-managing boss and judging coworkers into thinking you're still at the keyboard ...  have become reliant on tools like Microsoft Teams or Slack to determine when someone's \"at their desk.\" Some have even turned to VPNs and webcams to constantly monitor employees throughout the day. That's increased stress levels for some employees but it also inspired Rehaan Adatia, a consultant at KPMG, and Haris Akbar, a post-doctoral fellow at Vertex Pharmaceuticals, to find a way to help work-from-homers reclaim some control over their schedule. \"We were seeing an uptick in these micro-managing initiatives taken up by managers to really check in a little bit further on their employees,\" Adatia told Business Insider, adding that a survey they sent around online confirmed that others were having difficulties taking breaks without ... "], ["2020-05-22 15:51", "IBD Live Q&A And Two Key Stock Lists For May 22, 2020 ...  Interactv Sftwr TNDM Tandem Diabetes Care Inc TGT Target Corporation TDOC Teladoc Health Inc TSLA Tesla Inc TGTX TG Therapeutics Inc TTD The Trade Desk Inc Cl A TMO Thermo Fisher Scientific TW Tradeweb Markets Cl A TREX Trex Company Inc TWLO Twilio Inc Cl A TYL Tyler Technologies Inc RARE Ultragenyx Pharma UNH Unitedhealth Group Inc GDX Vaneck Vect Gold Miners VEEV Veeva Systems Inc Cl A VRTX Vertex Pharmaceuticals V Visa Inc Cl A WST West Pharmaceutical Svcs WPM Wheaton Precious Metals WING Wingstop Inc WIX Wix.com Ltd ZEN Zendesk Inc Z Zillow Group Inc Cl C ZM Zoom Video Comm Cl A ZS Zscaler Inc Today's Spotlight Save Big on SwingTrader! Ready to start swing trading? This week, try 6 weeks of SwingTrader for only $39\u2014that's $64 off! Try IBD ... "], ["2020-05-22 13:05", "7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine ...  more attention than usual, investors know they're less at risk of a consumer spending crunch that could hit tech companies like Apple ( NASDAQ: AAPL ). With that lead-up, here are seven biotech stocks that are positioned to pay off nicely. Co-Diagnostics (NASDAQ: CODX ) iBioPharma (NYSE: IBIO ) Moderna (NASDAQ: MRNA ) Biogen (NASDAQ: BIIB ) Gilead Sciences (NASDAQ: GLID ) Vertex Pharmaceuticals (NASDAQ: VRTX ) Inovio (NASDAQ: INO ) Some have seen their share price explode this year based on their Covid-19 involvement. Even so, that would just be the start should their research pay off. Compare Brokers Biotech Stocks to Buy: Co-Diagnostics (CODX) Source: Shutterstock You may have read my recent overview of Co-Diagnostics . This Utah-based biotech company ... "], ["2020-05-21 22:20", "Amazon Leads These 3 Hot Watchlist Stocks \u2014 Here's Where It's Smart To Buy ... bode well for biotech stocks to retain market leadership. Though biotech stocks can provide huge gains, the sector is known for its volatility. This is because of the headline risk associated with trial-result data. Plus, many products that are developed will never make it to market. Fahmy says investors can manage their risk in biotech stocks by investing in more established names like Vertex Pharmaceuticals ( VRTX ), which sees annual sales in the billions of dollars. \"If you're not comfortable, then a good way to play that so you reduce single stock risk is with an ETF,\" Fahmy added. One biotech ETF to note is IBB, which tracks the Nasdaq biotechnology index. Amazon Leads These Stocks To Watch In addition to several biotech leaders, Fahmy also ... "], ["2020-05-21 16:27", "IBD Live Q&A Summary, Key Lists For Thursday, May 21, 2020 ...  TGTX TG Therapeutics Inc TMO Thermo Fisher Scientific TMUS T-Mobile U.S. Inc TNDM Tandem Diabetes Care Inc TREX Trex Company Inc TSLA Tesla Inc TTD The Trade Desk Inc Cl A TTWO Take-Two Interactv Sftwr TW Tradeweb Markets Cl A TWLO Twilio Inc Cl A TYL Tyler Technologies Inc UNH Unitedhealth Group Inc V Visa Inc Cl A VEEV Veeva Systems Inc Cl A VRTX Vertex Pharmaceuticals WING Wingstop Inc WIX Wix.com Ltd WPM Wheaton Precious Metals WST West Pharmaceutical Svcs ZEN Zendesk Inc ZM Zoom Video Comm Cl A ZS Zscaler Inc ZTS Zoetis Inc Top Mutual Funds For Stock Research Symbol Name ALSAX ALGER SMALL CAP GROWTH A ACRNX Columbia Acorn Inst FCNTX Fidelity Contrafund FMAGX Fidelity Magellan FOCPX Fidelity OTC FKGRX Franklin Growth A VGRAX Invesco Mid Cap Growth A ... "], ["2020-05-21 16:00", "NORD Supports Rare Disease Nonprofits Impacted By COVID-19 With New Rapid Response Leadership Series ...  for Conferences, June 18 Activating Your Board in Crisis, July 8 Information on speakers for these presentations will be forthcoming. In addition, useful downloads and other resources will be added to the COVID-19 Rapid Response Leadership Series webpage in the days and weeks ahead. NORD is grateful for the generosity of Sanofi Genzyme, AveXis, Mallinckrodt Pharmaceuticals, Vertex Pharmaceuticals, and Blueprint Medicines, the founding sponsors of this program. For more information on NORD's COVID-19 patient assistance programs and regularly updated information for patients and rare disease nonprofits during the pandemic, visit our COVID-19 resource center, rarediseases.org /covid-19 . In order to continue to meet the community's needs during ... "], ["2020-05-21 13:56", "Dr. Reddy's (RDY) Q4 Earnings Increase Y/Y, Revenues Beat ...  erosion in the North America generics market, which will adversely impact sales. Dr. Reddys Laboratories Ltd Price Dr. Reddys Laboratories Ltd price | Dr. Reddys Laboratories Ltd Quote Zacks Rank & Key Picks Dr. Reddy's currently has a Zacks Rank #2 (Buy). Some other top-ranked stocks from the pharma/biotech sectors are AbbVie Inc. ( ABBV - Free Report ) , Eli Lilly and Company LLY and Vertex Pharmaceuticals Incorporated ( VRTX - Free Report ) , all sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here . AbbVie's earnings per share estimates have increased from $9.22 to $10.71 for 2020 and from $11.22 to $12.03 for 2021 in the past 30 days. The company delivered a positive earnings surprise ... "], ["2020-05-21 11:24", "Tread carefully if you're buying biotech stocks, traders say as group nears all-time highs ... he said. \"If it breaks below that level [at $227.43], that will also confirm that that stock, or the trend in that one, has broken down,\" Maley warned. Amgen rose less than half of 1% Wednesday, closing at $227.87. The IBB holds 211 stocks total weighted by market cap, meaning the largest companies account for the biggest chunk of its portfolio. Its top four holdings \u2014 Vertex Pharmaceuticals , Amgen, Gilead and Regeneron \u2014 account for nearly 30% of the ETF. \"If [Gilead and Amgen] start to break down, it could be a problem for the group,\" Maley said. \"Now, nobody wants to short any of these names because ... if you get a nice discovery on [a] Covid-19 vaccine, the group's going to go do very nicely. But I just think people ... "], ["2020-05-21 09:16", "The Virus Vaccine Race is Fueling Moderna Stock to New Highs ...  investors earlier this week. The group has a wide range of partnerships with other established names in the pharmaceutical sector. They include AstraZeneca (NYSE: AZN ), Merck (NYSE: MRK ), and Vertex (NASDAQ: VRTX ). Therefore, we can assume that these companies are also closely watching Moderna's current efforts. In case of any further potential developments, one of them or even ... large number of firms and research institutes are currently working on vaccine or drug development. Other publicly traded companies that investors are watching include Inovio Pharmaceuticals (NASDAQ: INO ), GlaxoSmithKline (NYSE: GSK ), Johnson & Johnson (NYSE: JNJ ), Gilead Sciences (NASDAQ: GILD ) and BioNTech (NASDAQ: BNTX ). So Moderna may also face competition from  ... "], ["2020-05-20 15:48", "U.S. House considering bill to extend timelines, make changes to small business loans: Pelosi ... increases COVID relief commitment, with an additional $25 million in grants, products and resources to small businesses planning to reopen PR Newswire Coast Offers Small Businesses Resources to Navigate PPP Loan Forgiveness PR Newswire What The Tiny Diamond On A Measuring Tape Is For Livestly Ad The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals Zacks NASA's head of human spaceflight resigns days before historic launch of astronauts USA TODAY In Suits Over Pandemic Conditions, Guards And Prisoners Find Themselves On The Same Side HuffPost New Jersey: Say Bye To Expensive Solar Panels EnergyBillCruncher Ad Amazon has tiny houses to buy for your backyard, and they're selling out fast In ... "], ["2020-05-20 15:15", "Targeted Protein Degradation (TPD) Insights Report 2020 - Includes Profiles Of TPD Technologies, Drug Candidates, TPD Technology Companies, And Major Pharma Companies With Stakes In TPD ...  Pharmaceutical Companies with Stakes in TPD 5.1 AbbVie5.2 Amgen5.3 AstraZeneca5.4 Bayer5.5 Biogen5.6 Bristol-Myers Squibb (& Celgene)5.7 Boehringer Ingelheim5.8 Calico Life Sciences5.9 Eisai5.10 Eli Lilly5.11 Gilead Sciences5.12 GlaxoSmithKline5.13 Janssen (Johnson & Johnson)5.14 LEO Pharma5.15 Merck5.16 Novartis5.17 Pfizer5.18 Roche5.19 Sanofi5.20 Vertex Pharmaceuticals 6 Profiles of TPD Technologies 6.1 PROTAC Protein Degradation (Arvinas)6.2 Daedalus Technology Platform (C4 Therapeutics)6.3 DELPHe Platform (Plexium)6.4 Pegasus Technology (Kymera)6.5 Protein Degradation by Intrinsic Pathways (Cedilla Therapeutics)6.6 Protein Hemostatic Modulators (BioTheryX)6.7 Targeted Protein Modulation (Nurix Therapeutics)6.8 uSMITE Technology (Cullgen) 7 Profiles of ... "], ["2020-05-20 14:12", "ViralClear Closes $10.8 Million Equity Financing For Development Of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib ...  (EP) procedures in an EP laboratory. About Merimepodib (MMPD) Merimepodib, a broad-spectrum anti-viral candidate, that demonstrates strong activity against COVID-19 in cell cultures in laboratory testing and additional antiviral studies are underway. Merimepodib was previously in development as a treatment for chronic hepatitis C and psoriasis by Vertex Pharmaceuticals Incorporated (Vertex), with 12 clinical trials conducted (including 315 chronic hepatitis C patients, 24 psoriasis patients, and 98 healthy volunteers) and an extensive preclinical safety package completed. A manuscript titled, \"The IMPDH inhibitor merimepodib provided in combination with the adenosine analogue remdesivir reduces SARS-CoV-2 replication to undetectable levels in ... "], ["2020-05-20 13:07", "The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex PharmaceuticalsThe Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals"], ["2020-05-20 13:06", "The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex PharmaceuticalsThe Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals"]]}}